Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H11N |
Molecular Weight | 121.1796 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC(C)=C1N
InChI
InChIKey=UFFBMTHBGFGIHF-UHFFFAOYSA-N
InChI=1S/C8H11N/c1-6-4-3-5-7(2)8(6)9/h3-5H,9H2,1-2H3
Molecular Formula | C8H11N |
Molecular Weight | 121.1796 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Hepatic effects of xylidine isomers in rats. | 1979 Jan |
|
Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure. | 1993 Jul |
|
An update of the National Toxicology Program database on nasal carcinogens. | 1997 Oct 31 |
|
Determination of the levels of aromatic amines in indoor and outdoor air in Italy. | 2001 Apr |
|
Synthesis, characterization, and comparative 32P-postlabeling efficiencies of 2,6-dimethylaniline-DNA adducts. | 2001 Feb |
|
Oxidation of 2,6-dimethylaniline by recombinant human cytochrome P450s and human liver microsomes. | 2001 Jun |
|
Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine. | 2002 Jun |
|
Asymmetric synthesis of axially chiral benzamides and anilides by enantiotopic lithiation of prochiral arene chromium complexes. | 2002 Mar 22 |
|
Determination of 2,6-dimethylaniline and o-toluidine impurities in preparations for local anaesthesia by the HPLC method with amperometric detection. | 2002 Sep-Oct |
|
Update on olfactory mucosal metabolic enzymes: age-related changes and N-acetyltransferase activities. | 2004 |
|
Synthesis, structure and pharmacology of acyl-2,6-xylidines. | 2004 May-Jun |
|
Metabolic activation of 2,6-xylidine in the nasal olfactory mucosa and the mucosa of the upper alimentary and respiratory tracts in rats. | 2004 Oct |
|
A kinetically controlled trans bifunctionalized organoimido derivative of the Lindqvist-type hexamolybdate: synthesis, spectroscopic characterization, and crystal structure of (n-Bu4N)2{trans-[Mo6O17(NAr)2]} (Ar = 2,6-dimethylphenyl). | 2005 Dec 26 |
|
Primary amido substituted diborane4 compounds and imidodiborate4 anions. | 2005 Oct 7 |
|
DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice. | 2006 Aug |
|
Production and characterization of laccase from Cyathus bulleri and its use in decolourization of recalcitrant textile dyes. | 2006 Aug |
|
Amine mediated proton transfer reaction and C-Cl bond activation of solvent chloroform by a trinuclear copper(II) complex of a glucopyranosylamine derived ligand. | 2006 Aug 21 |
|
Pi-Pi complexation of bupivacaine and analogues with aromatic receptors: implications for overdose remediation. | 2007 |
|
In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations. | 2007 Jan |
|
Assessment of the medicines lidocaine, prilocaine, and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues. | 2008 Aug |
|
The importance of CH/pi hydrogen bonds in rational drug design: An ab initio fragment molecular orbital study to leukocyte-specific protein tyrosine (LCK) kinase. | 2008 Dec 15 |
|
N-(2,6-Dimethyl-phen-yl)succinamic acid. | 2009 Feb 6 |
|
Kinetics of 2,6-dimethylaniline degradation by electro-Fenton process. | 2009 Jan 30 |
|
Ethyl 2-[(2,6-dimethyl-phen-yl)hydrazono]-3-oxobutanoate. | 2009 Jun 10 |
|
N-[3-(2,6-Dimethylanilino)-1-methylbut-2-enylidene]-2,6-dimethylanilinium chloride. | 2009 Jun 24 |
|
N-(2,6-Dimethyl-phen-yl)-2-(2-thien-yl)acetamide. | 2009 Nov 25 |
|
Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques. | 2009 Sep |
|
N-(2,6-Dimethyl-phen-yl)-4-methyl-benzene-sulfonamide. | 2010 Apr 24 |
|
N-(2,6-Dimethyl-phen-yl)succinimide. | 2010 Jan 9 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:09:07 GMT 2023
by
admin
on
Fri Dec 15 17:09:07 GMT 2023
|
Record UNII |
4FT62OX08D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
90502
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2,6-XYLIDINE
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
DTXSID8026307
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
4FT62OX08D
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
87-62-7
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
28738
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
C007766
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
m11552
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
7098
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
6896
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
201-758-7
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY | |||
|
2094
Created by
admin on Fri Dec 15 17:09:07 GMT 2023 , Edited by admin on Fri Dec 15 17:09:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
IN VITRO
|
||
|
PARENT -> METABOLITE INACTIVE |
has unknown pharmacologic activity but is carcinogenic in rats (http://srsid.fda.gov:9618/ePS/SubstanceRelationship.do?substanceMode=update&calledFrom=viewUpdateIngredient&RELATIONSHIP_ID=128538&SUBSTANCE_ID=1422&BDNUM=0021807AA).
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
color comparison
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|